INTRAVESICAL DOXORUBICIN FOR PROPHYLAXIS IN THE MANAGEMENT OF RECURRENT SUPERFICIAL BLADDER-CARCINOMA

被引:30
作者
GARNICK, MB
SCHADE, D
ISRAEL, M
MAXWELL, B
RICHIE, JP
机构
[1] DANA FARBER CANC INST,DIV PHARMACOL,BOSTON,MA 02115
[2] HARVARD UNIV,BRIGHAM & WOMEN HOSP,SCH MED,DIV UROL,BOSTON,MA 02115
关键词
D O I
10.1016/S0022-5347(17)50189-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:43 / 46
页数:4
相关论文
共 8 条
[1]   A CONTROLLED TRIAL OF SINGLE DOSE INTRAVESICAL ADRIAMYCIN IN SUPERFICIAL BLADDER-TUMORS [J].
ABRAMS, PH ;
CHOA, RG ;
GACHES, CGC ;
ASHKEN, MH ;
GREEN, NA .
BRITISH JOURNAL OF UROLOGY, 1981, 53 (06) :585-587
[2]   SUPERFICIAL BLADDER-CANCER - PROGRESSION AND RECURRENCE [J].
HENEY, NM ;
AHMED, S ;
FLANAGAN, MJ ;
FRABLE, W ;
CORDER, MP ;
HAFERMANN, MD ;
HAWKINS, IR .
JOURNAL OF UROLOGY, 1983, 130 (06) :1083-1086
[3]   LIQUID-CHROMATOGRAPHIC ANALYSIS OF ADRIAMYCIN AND METABOLITES IN BIOLOGICAL-FLUIDS [J].
ISRAEL, M ;
PEGG, WJ ;
WILKINSON, PM ;
GARNICK, MB .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1978, 1 (06) :795-809
[4]   THE USE OF INTRAVESICAL THIO-TEPA IN THE MANAGEMENT OF NON-INVASIVE CARCINOMA OF THE BLADDER [J].
KOONTZ, WW ;
PROUT, GR ;
SMITH, W ;
FRABLE, WJ ;
MINNIS, JE .
JOURNAL OF UROLOGY, 1981, 125 (03) :307-312
[5]  
PROUT GR, 1982, CANCER MED, P1896
[6]  
SCHULMAN CC, 1981, MAY ANN M AM UR ASS
[7]   THE MANAGEMENT OF SUPERFICIAL BLADDER-CANCER [J].
SOLOWAY, MS .
CANCER, 1980, 45 (07) :1856-1865
[8]   THE ANTICANCER AGENT ADRIAMYCIN CAN BE ACTIVELY CYTO-TOXIC WITHOUT ENTERING CELLS [J].
TRITTON, TR ;
YEE, G .
SCIENCE, 1982, 217 (4556) :248-250